Zafrens

📍 San Diego, United States🗓 Founded 2022👥 30 employees💰 Last funded Mar 2023
Biotechnology Research🌐 zafrens.com
Website LinkedIn
Zafrens is a therapeutics company pioneering an ultra-high throughput platform to isolate, culture, image, and sequence millions of cells per day. The proprietary platform allows for full characterization of diverse cell populations, as well as directly correlating molecular profiles (DNA, RNA, protein) to cell phenotype and function. The company’s mission is to unlock the full story of every cell to accelerate drug discovery.
4
Total investors
4
Early stage
0
Mid stage
0
Late stage
2022
Founded

Investors

4 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United States
4
Investor activity2021–2023 · investors recorded per year
2021220232
Recent (last 2y)Earlier
Frequently asked questions
Who invested in Zafrens?
Zafrens has 4 investors on record on gritt.io, including 4 early-stage backers.
When did Zafrens last raise funding?
The most recent investment in Zafrens recorded on gritt.io was in March 2023.
When was Zafrens founded?
Zafrens was founded in 2022.
What industry is Zafrens in?
Zafrens operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Zafrens based?
Zafrens is headquartered in San Diego, United States.